{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T19:22:02Z","timestamp":1774725722169,"version":"3.50.1"},"reference-count":44,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Methicillin-resistant Staphylococcus aureus (MRSA), known for its re-sistance to multiple antibiotics, has emerged as a major global health concern. It facilitates biofilm formation under stressful conditions by catalyzing the synthesis of alarmones (p)ppGpp and ppGpp. These alarmones on accumulation lead to biofilm formation and cause resistance towards antibiotics.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This condition has prompted the exploration of various novel approaches and methodolo-gies to combat MRSA infections. Among these, peptide therapeutics stand out as a promising next-generation treatment option. In this study, ninety antimicrobial peptides were sourced from the anti-microbial peptide database and the other sixty-one peptide sequences were designed using the Pep-draw server. These peptide sequences were screened out using different in-silico tools. The protein-peptide molecular interaction was studied using a molecular docking and molecular dynamic simu-lation technique.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results and Discussion:<\/jats:title>\n<jats:p>Out of 151 peptide sequences, Pantocin wh-1 emerged as the most promising drug candidate. Both molecular interaction studies and molecular dynamics simulations demonstrated positive re-sults.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Peptide therapeutics is a novel approach researchers are presently exploring as it pro-vides prompt significant results and promotes a new insight towards dealing with conditions like MDR. Pantocin wh-1 is a peptide drug currently listed as an accessible anti-tuberculosis peptide, and this study suggests the repurposing of this drug as a viable treatment option for MRSA infections.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701638337060250121154347","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T01:56:11Z","timestamp":1739498171000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In-silico Approach to Combat Methicillin-resistant Staphylococcus aureus: Targeting RelP Protein with Inhibitor Peptide to Mitigate Drug Resistance"],"prefix":"10.2174","volume":"22","author":[{"given":"Priyanka","family":"Sinoliya","sequence":"first","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooran Singh","family":"Solanki","sequence":"additional","affiliation":[{"name":"Birla Institute of Technology,\nMesra, India"},{"name":"Birla Institute of Scientific Research, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Ranjan Kumar","family":"Niraj","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Sharma","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, Rajasthan, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"Turner N.A.","year":"2019","unstructured":"Turner N.A.; Sharma-Kuinkel B.K.; Maskarinec S.A.; Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat Rev Microbiol  2019,17(4),203-218","journal-title":"Nat Rev Microbiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","volume":"21","author":"Hassoun A.","year":"2017","unstructured":"Hassoun A.; Linden P.K.; Friedman B.; Incidence, prevalence, and management of MRSA bacteremia across patient populations\u2014a review of recent developments in MRSA management and treatment. Crit Care  2017,21(1),211","journal-title":"Crit Care"},{"key":"ref=3","first-page":"269","volume":"90","author":"McGuinness W.A.","year":"2017","unstructured":"McGuinness W.A.; Malachowa N.; DeLeo F.R.; Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med  2017,90(2),269-281","journal-title":"Yale J Biol Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12551-021-00784-y","volume":"13","author":"Cardoso P.","year":"2021","unstructured":"Cardoso P.; Glossop H.; Meikle T.G.; Molecular engineering of antimicrobial peptides: Microbial targets, peptide motifs and translation opportunities. Biophys Rev  2021,13(1),35-69","journal-title":"Biophys Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1074\/jbc.RA117.001374","volume":"293","author":"Manav M.C.","year":"2018","unstructured":"Manav M.C.; Beljantseva J.; Bojer M.S.; Structural basis for (p)ppGpp synthesis by the Staphylococcus aureus small alarmone synthetase RelP. J Biol Chem  2018,293(9),3254-3264","journal-title":"J Biol Chem"},{"key":"ref=6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.575882","volume":"11","author":"Salzer A.","year":"2020","unstructured":"Salzer A.; Keinh\u00f6rster D.; K\u00e4stle C.; K\u00e4stle B.; Wolz C.; Small alarmone synthetases RelP and RelQ of Staphylococcus aureus are involved in biofilm formation and maintenance under cell wall stress conditions. Front Microbiol  2020,11","journal-title":"Front Microbiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"Pushpakom S.","year":"2019","unstructured":"Pushpakom S.; Iorio F.; Eyers P.A.; Drug repurposing: Progress, challenges and recommendations. Nat Rev Drug Discov  2019,18(1),41-58","journal-title":"Nat Rev Drug Discov"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","volume":"42","author":"Roessler H.I.","year":"2021","unstructured":"Roessler H.I.; Knoers N.V.A.M.; van Haelst M.M.; van Haaften G.; Drug repurposing for rare diseases. Trends Pharmacol Sci  2021,42(4),255-267","journal-title":"Trends Pharmacol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11696-021-01843-0","volume":"76","author":"Arooj M.","year":"2022","unstructured":"Arooj M.; Shehadi I.; Nassab C.N.; Mohamed A.A.; Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets. Chem Zvesti  2022,76(1),111-121","journal-title":"Chem Zvesti"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/prot.24677","volume":"83","author":"Arooj M.","year":"2015","unstructured":"Arooj M.; Sakkiah S.; Cao G.P.; Kim S.; Arulalapperumal V.; Lee K.W.; Finding off\u2010targets, biological pathways, and target diseases for chymase inhibitors via structure\u2010based systems biology approach. Proteins  2015,83(7),1209-1224","journal-title":"Proteins"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062740","volume":"8","author":"Arooj M.","year":"2013","unstructured":"Arooj M.; Kim S.; Sakkiah S.; Cao G.P.; Lee Y.; Lee K.W.; Molecular modeling study for inhibition mechanism of human chymase and its application in inhibitor design. PLoS One  2013,8(4)","journal-title":"PLoS One"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1021\/acs.jpcb.1c04614","volume":"125","author":"Nassab C.N.","year":"2021","unstructured":"Nassab C.N.; Arooj M.; Shehadi I.A.; Parambath J.B.M.; Kanan S.M.; Mohamed A.A.; Lysozyme and human serum albumin proteins as potential nitric oxide cardiovascular drug carriers: Theoretical and experimental investigation. J Phys Chem B  2021,125(28),7750-7762","journal-title":"J Phys Chem B"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1093\/nar\/gkg512","volume":"31","author":"Binkowski T.A.","year":"2003","unstructured":"Binkowski T.A.; Naghibzadeh S.; Liang J.; CASTp: Computed atlas of surface topography of proteins. Nucleic Acids Res  2003,31(13),3352-3355","journal-title":"Nucleic Acids Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/prot.24422","volume":"81","author":"Lavi A.","year":"2013","unstructured":"Lavi A.; Ngan C.H.; Movshovitz-Attias D.; Detection of peptide\u2010binding sites on protein surfaces: The first step toward the modeling and targeting of peptide\u2010mediated interactions. Proteins  2013,81(12),2096-2105","journal-title":"Proteins"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/nar\/gkh025","volume":"32","author":"Wang Z.","year":"2004","unstructured":"Wang Z.; APD: The antimicrobial peptide database. Nucleic Acids Res  2004,32(90001),590-592","journal-title":"Nucleic Acids Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"Wang G.","year":"2016","unstructured":"Wang G.; Li X.; Wang Z.; APD3: The antimicrobial peptide database as a tool for research and education. Nucleic Acids Res  2016,44(D1),D1087-D1093","journal-title":"Nucleic Acids Res"},{"key":"ref=17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"Gupta S.","year":"2013","unstructured":"Gupta S.; Kapoor P.; Chaudhary K.; Gautam A.; Kumar R.; Raghava G.P.S.; In silico approach for predicting toxicity of peptides and proteins. PLoS One  2013,8(9)","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"Dimitrov I.","year":"2014","unstructured":"Dimitrov I.; Naneva L.; Doytchinova I.; Bangov I.; Allergen F.P.; Allergen F.P.; Allergenicity prediction by descriptor fingerprints. Bioinformatics  2014,30(6),846-851","journal-title":"Bioinformatics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41467-021-27838-9","volume":"13","year":"2022","unstructured":"Tsaban t. Harnessing protein folding neural networks for peptide-protein docking. Nat Commun  2022,13(1),176","journal-title":"Nat Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1021\/acs.jcim.1c01114","volume":"61","author":"Skolnick J.","year":"2021","unstructured":"Skolnick J.; Gao M.; Zhou H.; Singh S.; AlphaFold 2: Why it works and its implications for understanding the relationships of protein sequence, structure, and function. J Chem Inf Model  2021,61(10),4827-4831","journal-title":"J Chem Inf Model"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx407","volume":"45","author":"Yan Y.","year":"2017","unstructured":"Yan Y.; Zhang D.; Zhou P.; Li B.; Huang S.Y.; HDOCK: A web server for protein\u2013protein and protein\u2013DNA\/RNA docking based on a hybrid strategy. Nucleic Acids Res  2017,45(W1)","journal-title":"Nucleic Acids Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Tao H.; He J.; Huang S.Y.; The HDOCK server for integrated protein\u2013protein docking. Nat Protoc  2020,15(5),1829-1852","journal-title":"Nat Protoc"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"Huang J.","year":"2013","unstructured":"Huang J.; MacKerell A.D.; CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J Comput Chem  2013,34(25),2135-2145","journal-title":"J Comput Chem"},{"key":"ref=24","author":"Bauer P.","year":"2022","unstructured":"Bauer P.; Hess B.; Lindahl E.;  GROMACS 20224 Manual  [https:\/\/manual.gromacs.org\/2022.4\/user-guide\/index.html2022","journal-title":"GROMACS 20224 Manual"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"Darden T.","year":"1993","unstructured":"Darden T.; York D.; Pedersen L.; Particle mesh Ewald: An N \u22c5log(N) method for Ewald sums in large systems. J Chem Phys  1993,98(12),10089-10092","journal-title":"J Chem Phys"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1063\/1.4872239","volume":"140","author":"Harrach M.F.","year":"2014","unstructured":"Harrach M.F.; Drossel B.; Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys  2014,140(17)","journal-title":"J Chem Phys"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463:AID-JCC4>3.0.CO;2-H","volume":"18","author":"Hess B.","year":"1997","unstructured":"Hess B.; Bekker H.; Berendsen H.J.C.; Fraaije J.G.E.M.; LINCS: A linear constraint solver for molecular simulations. J Comput Chem  1997,18(12),1463-1472","journal-title":"J Comput Chem"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"Bussi G.","year":"2007","unstructured":"Bussi G.; Donadio D.; Parrinello M.; Canonical sampling through velocity rescaling. J Chem Phys  2007,126(1)","journal-title":"J Chem Phys"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.90.075503","volume":"90","author":"Marto\u0148\u00e1k R.","year":"2003","unstructured":"Marto\u0148\u00e1k R.; Laio A.; Parrinello M.; Predicting crystal structures: The Parrinello-Rahman method revisited. Phys Rev Lett  2003,90(7)","journal-title":"Phys Rev Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"Vald\u00e9s-Tresanco M.S.","year":"2021","unstructured":"Vald\u00e9s-Tresanco M.S.; Vald\u00e9s-Tresanco M.E.; Valiente P.A.; Moreno E.; gmx_MMPBSA: A new tool to perform end-state free energy calculations with gromacs. J Chem Theory Comput  2021,17(10),6281-6291","journal-title":"J Chem Theory Comput"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"Miller B.R.","year":"2012","unstructured":"Miller B.R.; McGee T.D.; Swails J.M.; Homeyer N.; Gohlke H.; Roitberg A.E.; MMPBSA.py: An efficient program for end-state free energy calculations. J Chem Theory Comput  2012,8(9),3314-3321","journal-title":"J Chem Theory Comput"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1089\/mdr.2020.0001","volume":"26","author":"Hosseini M.","year":"2020","unstructured":"Hosseini M.; Shapouri Moghaddam A.; Derakhshan S.; Correlation between biofilm formation and antibiotic resistance in MRSA and MSSA isolated from clinical samples in Iran: A systematic review and meta-analysis. Microb Drug Resist  2020,26(9),1071-1080","journal-title":"Microb Drug Resist"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jam.15612","volume":"133","author":"Leshem T.","year":"2022","unstructured":"Leshem T.; Schnall B.S.; Azrad M.; Baum M.; Rokney A.; Peretz A.; Incidence of biofilm formation among MRSA and MSSA clinical isolates from hospitalized patients in Israel. J Appl Microbiol  2022,133(2),922-929","journal-title":"J Appl Microbiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/pathogens10080970","volume":"10","author":"Silva V.","year":"2021","unstructured":"Silva V.; Almeida L.; Gaio V.; Biofilm formation of multidrug-resistant mrsa strains isolated from different types of human infections. Pathogens  2021,10(8),970","journal-title":"Pathogens"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/diseases11040160","volume":"11","author":"Hern\u00e1ndez-Cuellar E.","year":"2023","unstructured":"Hern\u00e1ndez-Cuellar E.; Tsuchiya K.; Valle-R\u00edos R.; Medina-Contreras O.; Differences in biofilm formation by methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. Diseases  2023,11(4),160","journal-title":"Diseases"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"Drucker D.J.","year":"2019","unstructured":"Drucker D.J.; Advances in oral peptide therapeutics. Nat Rev Drug Discov  2019,19,277-289","journal-title":"Nat Rev Drug Discov"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.907314","volume":"12","author":"Plumet L.","year":"2022","unstructured":"Plumet L.; Ahmad-Mansour N.; Dunyach-Remy C.; Bacteriophage therapy for Staphylococcus Aureus infections: A review of animal models, treatments, and clinical trials. Front Cell Infect Microbiol  2022,12","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/cid\/ciab452","volume":"73","author":"Rose W.","year":"2021","unstructured":"Rose W.; Fantl M.; Geriak M.; Nizet V.; Sakoulas G.; Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does it work, which combination, and for which patients? Clin Infect Dis  2021,73(12),2353-2360","journal-title":"Clin Infect Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.drudis.2022.05.006","volume":"27","author":"Jampilek J.","year":"2022","unstructured":"Jampilek J.; Drug repurposing to overcome microbial resistance. Drug Discov Today  2022,27(7),2028-2041","journal-title":"Drug Discov Today"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/BST20200967","volume":"50","author":"Mullins J.G.L.","year":"2022","unstructured":"Mullins J.G.L.; Drug repurposing in silico screening platforms. Biochem Soc Trans  2022,50(2),747-758","journal-title":"Biochem Soc Trans"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103422","volume":"28","author":"Tan G.S.Q.","year":"2023","unstructured":"Tan G.S.Q.; Sloan E.K.; Lambert P.; Kirkpatrick C.M.J.; Ilom\u00e4ki J.; Drug repurposing using real-world data. Drug Discov Today  2023,28(1)","journal-title":"Drug Discov Today"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/1061186X.2021.1906884","volume":"29","author":"Timur S.S.","year":"2021","unstructured":"Timur S.S.; G\u00fcrsoy R.N.; The role of peptide-based therapeutics in oncotherapy. J Drug Target  2021,29(10),1048-1062","journal-title":"J Drug Target"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/molecules25030485","volume":"25","author":"Teng T.","year":"2020","unstructured":"Teng T.; Li X.; Zhang L.; Li Y.; Identification and Characterization of pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18. Molecules  2020,25(3),485","journal-title":"Molecules"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108081","volume":"110","author":"Suyash S.","year":"2024","unstructured":"Suyash S.; Jha A.; Maitra P.; Punia P.; Mishra A.; Differentiating stable and unstable protein using convolution neural network and molecular dynamics simulations. Comput Biol Chem  2024,110","journal-title":"Comput Biol Chem"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701638337060250121154347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239525\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701638337060250121154347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:44:49Z","timestamp":1753245889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239525\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701638337060250121154347","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15701638337060"}}